Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses available treatments for androgenetic alopecia in men, like finasteride and 5% minoxidil, and notes that hair growth results are unpredictable and often driven by industry-sponsored studies.

This study found that androgenetic alopecia can affect the occipital region in men with advanced stages of the condition.

This letter discusses existing research and encourages further studies on the relationship between androgenetic alopecia and COVID-19 severity, reporting no new clinical results.

This study aimed to determine if MRI can assess anatomical changes in the scalp caused by androgenetic alopecia, but it reports no new clinical results.

In this study, androgenetic alopecia patients with thin hair were found to have a higher likelihood of experiencing prostatic enlargement and related urinary symptoms compared to those with thicker hair.

In this case report, microneedling combined with PRP improved hair density and thickness in a 40-year-old man with androgenic alopecia, without side effects, suggesting it as a therapeutic option for those avoiding long-term pharmacotherapy.

In this study, 51.1% of patients with androgenetic alopecia showed more than 50% improvement after undergoing five microneedling sessions at four-week intervals.

In this cross-sectional study conducted at Farhat Hached Hospital in Tunisia, more than half of the 60 alopecia areata patients surveyed experienced depression, particularly younger individuals and those with severe or specific forms of the condition, underscoring the need for psychological support.

This study explores how Ayurveda concepts, specifically Prakruti, relate to male pattern baldness, suggesting that individual constitutional types may predict susceptibility to earlier hair loss when influenced by modern lifestyle factors.

This study found that combining fractional ablative erbium YAG laser with minoxidil led to slightly better dermoscopy scores than minoxidil alone in male patients with moderate to severe androgenetic alopecia, although no significant difference was observed in photography scores between the two groups.

This study found a very strong positive correlation between sebum levels and the severity of androgenetic alopecia in men.

This study investigates the potential link between atrial fibrillation and circulating aldosterone levels related to cardiac fibrosis in patients with hypertension.

In this hospital-based cross-sectional study, researchers observed that trichoscopy effectively differentiates between severe and mild male pattern hair loss by identifying specific features such as yellow and white dots, vellus hair, and hair shaft diversity.

This study found that platelet-rich plasma therapy was more effective in increasing hair count than topical 5% minoxidil lotion in men with androgenetic alopecia.

No link found between hair loss severity and PSA levels in men.

This study found no correlation between serum PSA levels and the severity of androgenetic alopecia at baseline in men.

This study found that metabolic syndrome was significantly more common in men with early-onset androgenetic alopecia compared to controls, indicating a potential increased risk of cardiovascular issues in this population.

In this study, platelet rich plasma treatment showed efficacy in improving hair count, thickness, and density in male patients with androgenetic alopecia.

This study found that a genetic test using 5 to 20 SNPs can predict male pattern baldness with variable accuracy in European men, especially those aged 50 and older.

This study found that the scalp coverage scoring (SCS) method is a non-invasive and reproducible technique that effectively measures hair growth and loss dynamics in male subjects with androgenetic alopecia.

This study concluded that visits to emergency and urgent care centers for severe sunburn treatment are largely avoidable and contribute to significant healthcare costs.

In this study, Taiwanese men with androgenetic alopecia who took 1 mg/day of finasteride for a year experienced slowed hair loss progression and increased hair growth, with minimal adverse effects reported.

This case report details a 28-year-old male with early-stage androgenetic alopecia who experienced significant hair density and thickness improvements following a three-month platelet-rich plasma therapy regimen, supporting its potential efficacy in similar cases.

In this case report, a 28-year-old male with androgenetic alopecia experienced significant improvement in hair density and shaft thickness after a three-month platelet-rich plasma therapy regimen, supporting existing literature on PRP's efficacy for early-to-moderate hair loss.

This study suggests that finasteride may be a safe and effective treatment for androgenetic alopecia in transgender men undergoing testosterone replacement therapy, though it may influence testosterone's effects.

In this case report, a 38-year-old male with androgenetic alopecia showed increased hair density and reduced follicular miniaturization after receiving UC-MSCs derived secretome injections, suggesting potential effectiveness and safety for hair restoration; further research is needed for broader validation.

In this cross-sectional study, researchers observed that patients undergoing hair transplant procedures showed significant improvements in hairline patterns, with most reverting to lower Norwood-Hamilton grades, after treatment at a tertiary care center in Balochistan, Pakistan.

In this study, injecting two different concentrations of botulinum toxin A was found to be safe and effective for treating androgenetic alopecia in Egyptian men and women, with improvements in hair grade and vellus hair density observed over six months.

This study found that oral Minoxidil 5 mg daily significantly improved androgenic alopecia in 90.2% of male participants after four months, with consistent effectiveness across different demographic and clinical subgroups.

This study found that in Taiwanese men with androgenetic alopecia, finasteride 1 mg/day over 1 year slowed hair loss and promoted hair growth, with minimal adverse effects.